Seeking AlphaThu, 07 May 2026 17:51:19 GMTCollegium Pharmaceutical, Inc. (COLL) Q1 2026 Earnings Call TranscriptCOLL-3.89%
Zacks Investment ResearchThu, 07 May 2026 14:31:29 GMTCollegium Pharmaceutical (COLL) Q1 Earnings: Taking a Look at Key Metrics Versus EstimatesCOLL-3.89%
Zacks Investment ResearchThu, 07 May 2026 13:56:20 GMTCollegium Pharmaceutical (COLL) Q1 Earnings and Revenues Beat EstimatesCOLL-3.89%
The Motley FoolTue, 31 Mar 2026 01:12:05 GMTCollegium's General Counsel Trims His Stake as the Company Doubles Down on ADHDCOLL-3.89%
The Motley FoolWed, 25 Mar 2026 13:59:54 GMTCollegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 MillionCOLL-3.89%
Seeking AlphaThu, 19 Mar 2026 23:32:21 GMTCollegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth TranscriptCOLL-3.89%
Seeking AlphaWed, 11 Mar 2026 15:52:18 GMTCollegium Pharmaceutical, Inc. (COLL) Presents at Barclays 28th Annual Global Healthcare Conference TranscriptCOLL-3.89%
Seeking AlphaThu, 26 Feb 2026 22:37:54 GMTCollegium Pharmaceutical, Inc. (COLL) Q4 2025 Earnings Call TranscriptCOLL-3.89%
Zacks Investment ResearchThu, 26 Feb 2026 18:30:34 GMTCollegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to SayCOLL-3.89%
Zacks Investment ResearchThu, 26 Feb 2026 18:16:34 GMTCollegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss EstimatesCOLL-3.89%
Zacks Investment ResearchThu, 19 Feb 2026 16:01:08 GMTCollegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseCOLL-3.89%
